MENU Quick Go

  • HOME
  • News
  • PharmAbcine Notice
PharmAbcine Notice
Total 173 search
No. Subject Date Count
173 Dr. Jin-San Yoo, CEO of PharmAbcine is joining for the ``Critical Issues in Tumor Microenvironment: Angiogenesis, Metastasis and Immunology`` of Tumor Course of Harvard Medical School and for networking on September 5-8th, 2017. 2017-09-04 136
172 Dr. Jin-San Yoo, CEO of PharmAbcine and Dr. Sung Woo Kim, Head of Business Development are requested to participate partnering meeting at INCHEON BIOPLUS 2017 - GLOBAL PARTNERING on September 13th, 2017. 2017-09-04 93
171 Dr. Jin-San Yoo, CEO of PharmAbcine and Dr. Sung Woo Kim, Head of Business Development are requested to participate partnering meeting with Novartis BD&L on September 15th, 2017. 2017-08-24 175
170 Dr. Jin-San Yoo, CEO of PharmAbcine will present as invited speaker at NOVARTIS GLOBAL PARTNERING CONFERENCE on September 14th, 2017. 2017-08-24 139
169 Dr. Jin-San Yoo, CEO of PharmAbcine is invited to present as panelist at KoNECT-KDDF GLOBAL CLINICAL DEVELOPMENT FORUM on August 17th, 2017. 2017-08-15 100
168 Dr. Lawrence Cher at Olivia Newton-Johns Cancer Wellness & Research Center/Austin Hospital is invited to present the interim data of Tanibirumab phase IIa recurrent GBM trial at 2017 SNO (Society for NeuroOncology) meeting in San Francisco on November 16- 2017-07-30 133
167 PharmAbcine`s ``BI(Business Incubation) Research Grant`` proposal is granted by KIAT. 2017-07-07 556
166 Dr. Jin-San Yoo, CEO of PharmAbcine is invited to present for ``Investor Relation`` at MIRAE ASSET DAEWOO SECURITIES Corporate Day on July 12th, 2017. 2017-07-07 302
165 Interview of Dr. Jin-San Yoo, CEO of PharmAbcine with Bio-Pod 2017-05-10 507
164 Dr. Jin-San Yoo, CEO of PharmAbcine is presenting at the forum for future pharm in Seoul on June 23, 2017. 2017-05-10 449
1 2 3 4 5 6 7 8 9 10